To determine the prevalence of neuroimaging abnormalities in individuals with Down Syndrome Regression Disorder (DSRD) and evaluate if neuroimaging abnormalities were predictive of therapeutic responses.
No takes yet. Share an insight, caveat, or question.
Santoro et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: